SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap's stock is surging as investors react to a Q3 earnings beat, a $500 million stock buyback, and a new $400 million AI partnership with Perplexity. The community is buzzing about the potential for a short squeeze and upgraded price targets, while also weighing concerns about profitability and the long-term sustainability of the rally.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending as investors anticipate upcoming earnings results, with many in the community expecting strong numbers driven by growth and the Alani Nu acquisition. Despite overall market uncertainty, the community expresses long-term confidence in CELH's execution and potential, while also closely monitoring potential short-term volatility and market manipulation.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors anticipate Phase 3 data for their DMD treatment, deramiocel, expected mid-Q4, with the community actively discussing potential FDA approval pathways. Discussions also involve the StealthX exosome platform and recent job postings at Capricor and NS Pharma, hinting at possible positive outcomes. Community members are closely monitoring short interest and options activity, speculating on potential market reactions following the data release.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT) is trending as community members discuss its tokenomics, specifically the locked dev tokens until February and scheduled buybacks, which some believe will naturally increase the coin price.  Concerns about competitors potentially suppressing the token's price and calls for fair play are also circulating.  Traders are actively watching key price levels and anticipating potential volatility, with some suggesting it's time for a rebound.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending as traders assess the semiconductor sector's near-term trajectory amidst AI optimism and US-China trade concerns. Community discussions include reactions to earnings reports from key semiconductor companies and speculation about upcoming economic data releases and Federal Reserve actions. Bullish sentiment persists, while some are wary of overvaluation and the potential for a pullback.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as the community discusses its potential for future growth and staking opportunities. Many users are accumulating and staking $SWEAT, motivated by the project's concept of earning crypto through walking and its potential for long-term gains. The conversation also highlights anticipation for increased utility and adoption of the Sweat Wallet in the US.

Caledonia Mining Corp. Plc engages in the exploration, development, and production of gold and other precious metals from its mineral properties. Its projects include Blanket Gold Mine and Maligreen. The company was founded on February 5, 1992 and is headquartered in St. Helier, the United Kingdom.

Caledonia Mining Corporation Plc

Caledonia Mining Corporation ($CMCL) is trending due to upcoming earnings and discussions around its potential growth, particularly the Bilboes project which could significantly increase production; the earnings are scheduled to be released Monday before the market opens. Community members are weighing the company's profitability against the political risks of operating in Zimbabwe, with some anticipating a positive impact from rising gold prices and others concerned about potential dilution from financing activities. Recent discussions also touch on the stock's valuation relative to its growth potential and comparison to other gold miners.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

DVAX is trending due to a new $100 million share buyback program and updates regarding a partnership with VXRT for a novel oral COVID-19 vaccine. The community is discussing the potential financial benefits and strategic implications of this agreement, as well as concerns about delays in the FDA study protocol for HLAD in adults on hemodialysis. Investors are also weighing in on the impact of Deep Track's involvement and management's capital allocation decisions.

Chime Financial, Inc. engages in the design and development of a digital banking application. Its mobile app, Chime, provides online banking, fee-free overdraft, mobile banking, automatic savings, mobile payments, and security and control capabilities. The company was founded by Christopher R. Britt and Ryan King in 2012 and is headquartered in San Francisco, CA.

Chime Financial Inc - Ordinary Shares - Class A

Chime Financial, Inc.

Chime Financial's stock is trending amid discussions about its recent earnings report, which appears to have surpassed expectations, including a share repurchase program. The community is debating the sustainability of some revenue streams and expressing varied opinions on the company's valuation relative to its peers. Some investors believe the stock is undervalued and poised for growth, while others cite concerns about a potential lockup expiration and competition.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is trending amid discussions about its drug ziftomenib and its potential competition with Syndax's Revuforj, particularly regarding safety profiles and efficacy in treating AML. Community members are debating the clinical and legal implications of Revuforj's black box warning for cardiac risk compared to ziftomenib, with some suggesting Kura's drug may become the preferred choice for doctors due to its potentially cleaner safety profile. Investors are also closely watching for the PDUFA approval decision expected by the end of November.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Retail traders on Stocktwits praised Chevron Corp.’s (CVX) key legal battle win, removing a significant roadblock in its $53 billion plan to acquire Hess Corp. (HES).According to a CNBC&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/07/18/chevron-defeats-exxon-in-dispute-over-guyana-oil-assets-clearing-path-for-hess-acquisition.html">report</a>, the International Chamber of Commerce decided against ExxonMobil Corp. (XOM) and China National Offshore Oil Corp. (CNOOC), which claimed they had the first opportunity to acquire Hess's 30% stake in the valuable Stabroek Block.<a href="https://stocktwits.com/symbol/CVX">Chevron stock</a> traded up more than 1% on Friday morning, following the completion of the acquisition.&nbsp;A bullish user stated that Chevron holds good risk-reward potential after the deal.<stembedurl>https://stocktwits.com/theoptionsplug/message/621487340</stembedurl>Another user said the legal win paves the way for a huge dividend yield.<stembedurl>https://stocktwits.com/ClarityOfPurpose/message/621469946</stembedurl>An ExxonMobil trader commented that, with the end of the legal dispute, Exxon should now concentrate on its shareholders.<stembedurl>https://stocktwits.com/StagflationRecession/message/621474178</stembedurl>The arbitration centered on whether Exxon and its partner CNOOC had legal grounds to block the transaction under joint operating agreements tied to the offshore Guyanese asset.&nbsp;Exxon operates the Stabroek Block with a 45% stake, while CNOOC holds a 25% stake, and Hess owns the remaining 30%.Despite disagreeing with the panel’s interpretation, Exxon acknowledged the outcome.&nbsp;“We disagree with the ICC panel’s interpretation but respect the arbitration and dispute resolution process. As we’ve said before, ExxonMobil and CNOOC are aligned that we had a duty to ensure contract terms are always adhered to and not set a bad precedent for ourselves and industry,” Exxon said in a statement on Friday.The uncertainty had been a drag on Chevron’s stock in recent months, with the stock adding just 5% year-to-date and shedding 6% in the past 12 months.Through the acquisition, Chevron aims to reduce costs by $1 billion by the end of 2025.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/top-tech-stocks-with-most-retail-chatter/ch8kpvwR5q0">Top Tech Stocks With Most Retail Chatter: Bit Origin Rockets On Dogecoin Plan, Netflix Beats Q2, Inuvo Climbs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Chevron Corporation is displayed on a smartphone screen, with the company's iconic red and blue branding visible in the background.

Traders Eye Good Risk-Reward Potential, Huge Dividend Yield As Chevron Defeats Exxon In $53B Legal Battle

Retail traders cited dividend potential and improved energy outlook as key bullish drivers after Chevron’s legal win over Exxon and CNOOC cleared the way for its Hess deal. 

Equity

Retail traders cited dividend potential and improved energy outlook as key bullish drivers after Chevron’s legal win over Exxon and CNOOC cleared the way for its Hess deal. 


Chevron Completes Acquisition of Hess Corporation

Chevron Corporation (NYSE: CVX) announced today that it has completed its acquisition of Hess Corporation (NYSE: HES) following the satisfaction of all necessary closing conditions, including a...

Core Laboratories to Post Q2 Earnings: Key Metrics to Watch

CLB's second-quarter revenues are likely to have declined from the year-ago period's level due to weak segment revenues.

OXY Stock is Trading Above 50-Day SMA: Time to Buy, Hold or Sell?

OXY is trading above its 50-day SMA after a 22.5% rally, fueled by Permian strength and international assets.

How to Boost Your Portfolio with Top Oils and Energy Stocks Set to Beat Earnings

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Strength Seen in Hess (HES): Can Its 4.8% Jump Turn into More Strength?

Hess (HES) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Company News for Jul 9, 2025

Companies in The News Are: FCX, MRNA, NRG, HES

Hess Exits Suriname's Offshore Block 59 Amid Drilling Risks

HES exits Suriname's offshore Block 59, capping years of risky exploration after XOM and EQNR pulled out earlier.

Final Decision Reached on Chevron's Disputed Hess Acquisition 

CVX nears a decisive moment as arbitrators take final decision on its $53 billion Hess deal and entry into Guyana's top-tier oilfield.

Why Hess (HES) is Poised to Beat Earnings Estimates Again

Hess (HES) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Hess Corp is an exploration and production company, which engages in exploration, development, production, transportation, purchase & sale of crude oil, natural gas liquids and natural gas with production operations. It operates through the following segments: Exploration and Production and Midstream. The Exploration and Production segment explores for, develops, produces, purchases and sells crude oil, natural gas liquids and natural gas. The Midstream segment provides fee-based services including crude oil and natural gas gathering, processing of natural gas and the fractionation of natural gas liquids, transportation of crude oil by rail car, terminaling and loading crude oil and natural gas liquids, and the storage and terminaling of propane, primarily in the Bakken shale play of North Dakota. The company was founded by Leon Hess in 1920 and is headquartered in New York, NY.

HES
Hess Corporation

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HES News

HESHess Corporation